12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 11.1% to $1.3 during Tuesday’s after-market session. The company’s market…
What’s Going On With Capricor Therapeutics Stock Tuesday?
Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).
What’s Going On With Capricor Therapeutics Stock Tuesday?
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension
Capricor Therapeutics Reports 3-Year Efficacy Results From HOPE-2 Open Label Extension Study Of CAP-1002 In DMD
--Results in Performance of the Upper Limb (PUL 2.0) Continue to Show Benefits in Skeletal Muscle Function After 3 Years of CAP-1002 Treatment (p< 0.001)-- --Stabilization in Left Ventricular Ejection Fraction
Expert Ratings For Capricor Therapeutics
During the last three months, 5 analysts shared their evaluations of Capricor Therapeutics (NASDAQ:CAPR), revealing diverse outlooks from…
Capricor Therapeutics To Present Exosome Platform Updates At ASGCT 27th Annual Meeting; Preclinical Findings Show Exosome-Based Therapeutic Approach For The Treatment Of Arginase-1 Deficiency
-Preclinical findings show exosome-based therapeutic approach for the treatment of arginase-1 deficiency (ARG1-D)- -Presentation to be featured in an oral session being held on May 9, 2024-SAN DIEGO, May 09, 2024
Earnings Scheduled For November 14, 2023
Companies Reporting Before The Bell
• CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
Preview: Capricor Therapeutics’s Earnings
Capricor Therapeutics (NASDAQ:CAPR) is set to give its latest quarterly earnings report on Tuesday, 2023-11-14. Here’s what investors…
Capricor Therapeutics And Parent Project Muscular Dystrophy To Host Webinar To Review Latest Developments Of CAP-1002 Program
Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases,
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
The Dow Jones closed higher by around 65 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.